Mirum Pharmaceuticals (MIRM) Other Non Operating Income (2019 - 2025)
Mirum Pharmaceuticals' (MIRM) quarterly Other Non Operating Income came in at -$218000.0 in Q4 2025, up 77.8% year-on-year from -$122609.4 in Q4 2024, and down 155.19% quarter-over-quarter from $395000.0 in Q3 2025.
Mirum Pharmaceuticals (MIRM) Other Non Operating Income (2019 - 2025) Analysis & Trends
Mirum Pharmaceuticals' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$218000.0 for Q4 2025.
- On a quarterly basis, Other Non Operating Income rose 77.8% year-over-year to -$218000.0 in Q4 2025; TTM through Mar 2026 was $263000.0, a 25.07% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, changed N/A from the prior year.
- Other Non Operating Income fell to -$218000.0 in Q4 2025 per MIRM's latest filing, from $395000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $46.3 million in Q4 2023 and bottomed at -$49.1 million in Q2 2023.
- The 5-year median for Other Non Operating Income is -$17000.0 (2021), against an average of -$96176.5.
- Across the five-year window, Other Non Operating Income tumbled 862.5% in 2022 and jumped 12571.78% in 2023, its largest moves.
- Year by year, Other Non Operating Income stood at -$17000.0 in 2021, then jumped by 2247.06% to $365000.0 in 2022, then soared by 12571.78% to $46.3 million in 2023, then sank by 102.12% to -$982000.0 in 2024, then surged by 77.8% to -$218000.0 in 2025.
- Per Business Quant, the three latest MIRM Other Non Operating Income figures stand at -$218000.0 (Q4 2025), $395000.0 (Q3 2025), and $86000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -218,000.00 |
| Sep 30, 2025 | 395,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | -982,000.00 |
| Sep 30, 2024 | -1.09 Mn |
| Jun 30, 2024 | 312,000.00 |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 46.25 Mn |
| Jun 30, 2023 | -49.08 Mn |
| Mar 31, 2023 | -811,000.00 |
| Dec 31, 2022 | 365,000.00 |
| Mar 31, 2022 | -154,000.00 |
| Dec 31, 2021 | -17,000.00 |
| Sep 30, 2021 | -35,000.00 |
| Jun 30, 2021 | -514,000.00 |
| Mar 31, 2021 | -16,000.00 |
| Dec 31, 2020 | -83,000.00 |
| Sep 30, 2020 | -30,000.00 |
| Jun 30, 2020 | -56,000.00 |